Article
Passing the baton: the HIF switch.
Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Trends in Biochemical Sciences (impact factor:
10.85).
07/2012;
37(9):364-72.
DOI:10.1016/j.tibs.2012.06.004
pp.364-72
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Clinical Relevance of Hif-1a, Cox-2, Leptin, and Prolactin as Hypoxic Markers in Breast Cancer
[show abstract] [hide abstract]
ABSTRACT: Key words: Breast neoplasms, hypoxia-inducible factor-1α (HIF-1α), neovascularization, cyclooxygenase-2 (Cox-2), leptin (LEP), prolactin (PRL). abstract Background: Hypoxia is a critical event in tumor neovascularization process. It affects prolactin (PRL) and stimulates hypoxia-inducible factor-1α (HIF-1α) which can induce other genes such as cyclooxygenase-2 (Cox-2) and leptin (LEP).Austral - Asian Journal of Cancer. 10/2012; 11(4):237-246.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
cell lines
chronic response
HIF target gene activation
HIF-1
HIF-2
HIF-2 drives
hypoxia
hypoxia-inducible transcription factors
inadequate oxygen supply
individual HIFs
pathophysiological conditions
reliable indicator
unique target genes